Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' Equity (Deficiency)

v3.3.1.900
Consolidated Statements of Changes in Shareholders' Equity (Deficiency) - USD ($)
Total
Preferred Stock [Member]
Common Stock [Member]
Shares To Be Issued [Member]
Additional Paid-in Capital [Member]
Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Opening Balance at Mar. 31, 2014 $ (774,626) $ 0 $ 36,622   $ 1,736,247 $ (2,589,235) $ 41,740
Opening Balance (in shares) at Mar. 31, 2014   0 36,621,885        
Issuance of common shares for cash (Note 8(i)) 2,616,062 $ 0 $ 10,792   2,605,270 0 0
Issuance of common shares for cash (in shares) (Note 8(i))   0 10,792,335        
Shares issues on conversion of loans (Notes 8(ii) and (iii)) 239,746 $ 0 $ 1,012   238,734 0 0
Shares issues on conversion of loans (in shares) (Notes 8(ii) and (iii))   0 1,012,142        
Beneficial conversion feature (Note 6) 27,677 $ 0 $ 0   27,677 0 0
Shares issued on exercise of stock options 228,875 $ 0 $ 1,311   227,564 0 0
Shares issued on exercise of stock options (in shares)   0 1,310,734        
Share issue costs (Note 8(i)) (11,609) $ 0 $ 0   (11,609) 0 0
Share compensation expense (Note 9) 112,573 $ 0 $ 0 $ 0 112,573 0 0
Share compensation expense (in shares) (Note 9)   0 0        
Net loss for the year/period (2,464,747) $ 0 $ 0   0 (2,464,747) 0
Foreign currency translation (24,390) 0 0   0 0 (24,390)
Closing Balance at Dec. 31, 2014 (50,439) $ 0 $ 49,737   4,936,456 (5,053,982) 17,350
Closing Balance (in shares) at Dec. 31, 2014   0 49,737,096        
Effect of the Reverse Acquisition 0 $ 0 $ 6,000 0 (6,000) 0 0
Effect of the Reverse Acquisition (in shares)   1 6,000,063        
Shares issued on private placement (Notes 8(v) and (xii)) 4,789,404 $ 0 $ 16,408 0 4,772,996 0 0
Shares issued on private placement (in shares) (Notes 8(v) and (xii))   0 16,408,250        
Shares to be issued for services (Note 8(xiii)) 98,900 $ 0 $ 0 98,900 0 0 0
Shares to be issued for services (in shares) (Note 8(xiii))   0 0        
Share compensation expense (Note 9) 1,709,230 $ 0 $ 283 0 1,708,947 0 0
Share compensation expense (in shares) (Note 9)   0 282,904        
Net loss for the year/period (5,593,906) $ 0 $ 0   0 (5,593,906) 0
Foreign currency translation 24,799 0 0   0 0 24,799
Closing Balance at Dec. 31, 2015 $ 977,988 $ 0 $ 72,428 $ 98,900 $ 11,412,399 $ (10,647,888) $ 42,149
Closing Balance (in shares) at Dec. 31, 2015   1 72,428,313